Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

Annals of Neurology

Volumn 45, Issue 2, 1999, Pages 259-261

  Antinori, Andrea ^a   Cingolani, Antonella ^a   De Luca, Andrea ^a   Gaidano, Gianluca ^b   Ammassari, Adriana ^a   Larocca, Luigi M ^a   Ortona, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LATENT MEMBRANE PROTEIN 1; METHOTREXATE; ONCOPROTEIN; PROCARBAZINE; PROTEIN BCL X; VIRUS DNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN RADIATION; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 0033007018     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199902)45:2<259::AID-ANA19>3.0.CO;2-G     Document Type: Article

References (11)

1. MacMahon EME, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-973
2. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342: 398-401
3. De Luca A, Antinori A, Cingolani A, et al. Evaluation of CSF EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995;90:844-849
4. Arribas JR, Clifford DB, Fichtenbaum CJ, et al. Detection of Epstein-Barr virus DNA in CSF for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 1995;33: 1580-1583
5. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997; 48:687-694
6. Cingolani A, De Luca A, Larocca LM, et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome - related primary central nervous system lymphoma. J Natl Cancer Inst 1998;90:364-369
7. Yarchoan R, Jaffe ES, Little R. Diagnosing central nervous system lymphoma in the setting of AIDS: a step forward. J Natl Cancer Inst 1998;90:346-347
8. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135
9. Harris NL, Jaffem ES, Stain H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84: 1361-1392
10. Larocca LM, Capello D, Rinelli A, et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the diseases and is consistent withhistogenetic derivation from germinal center-related B-cells. Blood 1988;92:1011-1019
11. Forsyth PA, Yahalom J, DeAngelis LM. Combined-modaliry therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994;44:1473-1479